| Chimeric antigen receptor T cells for sustained remissions in leukemia SL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, ... New England Journal of Medicine 371 (16), 1507-1517, 2014 | 5680 | 2014 |
| Chimeric antigen receptor–modified T cells for acute lymphoid leukemia SA Grupp, M Kalos, D Barrett, R Aplenc, DL Porter, SR Rheingold, ... New England Journal of Medicine 368 (16), 1509-1518, 2013 | 4038 | 2013 |
| Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo MC Milone, JD Fish, C Carpenito, RG Carroll, GK Binder, D Teachey, ... Molecular therapy 17 (8), 1453-1464, 2009 | 1379 | 2009 |
| Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia DT Teachey, SF Lacey, PA Shaw, JJ Melenhorst, SL Maude, N Frey, ... Cancer discovery 6 (6), 664-679, 2016 | 983 | 2016 |
| Managing cytokine release syndrome associated with novel T cell-engaging therapies SL Maude, D Barrett, DT Teachey, SA Grupp The Cancer Journal 20 (2), 119-122, 2014 | 836 | 2014 |
| Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia KG Roberts, RD Morin, J Zhang, M Hirst, Y Zhao, X Su, SC Chen, ... Cancer cell 22 (2), 153-166, 2012 | 835 | 2012 |
| CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia SL Maude, DT Teachey, DL Porter, SA Grupp Blood, The Journal of the American Society of Hematology 125 (26), 4017-4023, 2015 | 806 | 2015 |
| Gene therapy in patients with transfusion-dependent β-thalassemia AA Thompson, MC Walters, J Kwiatkowski, JEJ Rasko, JA Ribeil, ... New England Journal of Medicine 378 (16), 1479-1493, 2018 | 690 | 2018 |
| Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy DT Teachey, SR Rheingold, SL Maude, G Zugmaier, DM Barrett, AE Seif, ... Blood, The Journal of the American Society of Hematology 121 (26), 5154-5157, 2013 | 661 | 2013 |
| Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop JB Oliveira, JJ Bleesing, U Dianzani, TA Fleisher, ES Jaffe, MJ Lenardo, ... Blood, The Journal of the American Society of Hematology 116 (14), e35-e40, 2010 | 515 | 2010 |
| Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia JC Fitzgerald, SL Weiss, SL Maude, DM Barrett, SF Lacey, JJ Melenhorst, ... Critical care medicine 45 (2), e124-e131, 2017 | 441 | 2017 |
| Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2 C Diorio, SE Henrickson, LA Vella, KO McNerney, J Chase, ... The Journal of clinical investigation 130 (11), 5967-5975, 2020 | 412 | 2020 |
| Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia SL Maude, SK Tasian, T Vincent, JW Hall, C Sheen, KG Roberts, AE Seif, ... Blood, The Journal of the American Society of Hematology 120 (17), 3510-3518, 2012 | 352 | 2012 |
| Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome C Kotch, D Barrett, DT Teachey Expert review of clinical immunology 15 (8), 813-822, 2019 | 286 | 2019 |
| Treatment of E pstein B arr virus‐induced haemophagocytic lymphohistiocytosis with rituximab‐containing chemo‐immunotherapeutic regimens DB Chellapandian, R Das, K Zelley, SJ Wiener, H Zhao, DT Teachey, ... British journal of haematology 162 (3), 376-382, 2013 | 267 | 2013 |
| T-cell acute lymphoblastic leukemia EA Raetz, DT Teachey Hematology 2014, the American Society of Hematology Education Program Book …, 2016 | 266 | 2016 |
| Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia SL Maude, S Dolai, C Delgado-Martin, T Vincent, A Robbins, ... Blood, The Journal of the American Society of Hematology 125 (11), 1759-1767, 2015 | 246 | 2015 |
| Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) DT Teachey, CS Manno, KM Axsom, T Andrews, JK Choi, BH Greenbaum, ... Blood 105 (6), 2443-2448, 2005 | 211 | 2005 |
| Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial KL Bride, T Vincent, K Smith-Whitley, MP Lambert, JJ Bleesing, AE Seif, ... Blood, The Journal of the American Society of Hematology 127 (1), 17-28, 2016 | 209 | 2016 |
| Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit'ALL' SS Neelapu, S Tummala, P Kebriaei, W Wierda, FL Locke, Y Lin, N Jain, ... Nature reviews Clinical oncology 15 (4), 218-218, 2018 | 205 | 2018 |
